Liminatus Pharma (LIMN) Interest Expenses (2024 - 2026)
Liminatus Pharma (LIMN) posted Interest Expenses of $18638.0 for Q1 2026, up 110.92% sequentially from -$170601.0 in Q4 2025, and down 83.86% YoY from $115512.0 in Q1 2025.
Liminatus Pharma (LIMN) Interest Expenses (2024 - 2026) Analysis & Trends
Liminatus Pharma has reported Interest Expenses for 3 years, with the latest figure at $18638.0 in Q1 2026.
- Quarterly Interest Expenses fell 83.86% year-over-year to $18638.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$70623.0 (down 112.96% YoY) and the FY2025 annual result came in at $2.3 million, up 592.21% from the prior year.
- Interest Expenses improved to $18638.0 in Q1 2026 per LIMN's latest filing, from -$170601.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $259628.0 in Q4 2024 and troughed at -$170601.0 in Q4 2025.
- A 3-year average of $59305.4 and a median of $69754.0 in 2024 frame the typical range for Interest Expenses.
- The widest YoY moves for Interest Expenses: up 19.34% in 2025, down 165.71% in 2025.
- Over 3 years, Interest Expenses stood at $259628.0 in 2024, then plunged by 165.71% to -$170601.0 in 2025, then soared by 110.92% to $18638.0 in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $18638.0, -$170601.0, and $19052.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Liminatus Pharma | 256.03 Mn | 256.03 Mn | - | 18,844.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,638.00 |
| Mar 31, 2026 | 18,638.00 |
| Dec 31, 2025 | -170,601.00 |
| Dec 31, 2025 | -170,601.00 |
| Sep 30, 2025 | 19,052.00 |
| Sep 30, 2025 | 19,052.00 |
| Jun 30, 2025 | 62,288.00 |
| Jun 30, 2025 | 62,288.00 |
| Mar 31, 2025 | 115,512.00 |
| Mar 31, 2025 | 115,512.00 |
| Dec 31, 2024 | 259,628.00 |
| Dec 31, 2024 | 259,628.00 |
| Sep 30, 2024 | 92,706.00 |
| Sep 30, 2024 | 92,706.00 |
| Jun 30, 2024 | 77,220.00 |
| Jun 30, 2024 | 77,220.00 |